Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting125%
unknown125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

NCT06032208
completednot_applicable

Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

NCT03640858
completednot_applicable

Theranova vs High-flux HD Comparison

NCT04106310
unknown

Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)

NCT03169400

Clinical Trials (4)

Showing 4 of 4 trials
NCT06032208Not Applicable

An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

Recruiting
NCT03640858Not Applicable

Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

Completed
NCT04106310Not Applicable

Theranova vs High-flux HD Comparison

Completed
NCT03169400

Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4